dacarbazine has been researched along with Complex and Mixed Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, JS; Choi, S; Choi, YL; Han, J; Jung, HA; Kim, Y; Lee, J; Lee, SH; Park, K; Sun, JM | 1 |
| Amano, T; Fujioka, Y; Hata, N; Iwaki, T; Mizoguchi, M; Murata, H; Nakamizo, A; Sasaki, T; Suzuki, SO; Yoshimoto, K | 1 |
| Agarwal, A; Churi, S; Epari, S; Goda, JS; Gupta, T; Jalali, R; Lewis, S; Moiyadi, A; Padmavati, A; Shetty, P | 1 |
3 other study(ies) available for dacarbazine and Complex and Mixed Neoplasms
| Article | Year |
|---|---|
Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinoma.
Topics: Adult; Aged; Dacarbazine; Doxorubicin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Neoplasms, Complex and Mixed; Retrospective Studies; Sarcoma; Survival Analysis | 2018 |
Pediatric glioblastoma with oligodendroglioma component: aggressive clinical phenotype with distinct molecular characteristics.
Topics: Brain Neoplasms; Chemoradiotherapy; Child; Dacarbazine; Fatal Outcome; Glioblastoma; Humans; Male; Microsatellite Instability; Neoplasms, Complex and Mixed; Neurosurgical Procedures; Oligodendroglioma; Phenotype; Temozolomide | 2013 |
Impact of oligodendroglial component in glioblastoma (GBM-O): Is the outcome favourable than glioblastoma?
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Humans; Karnofsky Performance Status; Male; Middle Aged; Neoplasms, Complex and Mixed; Neurosurgical Procedures; Oligodendroglioma; Prognosis; Temozolomide; Treatment Outcome; Young Adult | 2015 |